Japan, July 1 -- XENCOR INC has got intellectual property rights for 'HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3.' Other related details are as follows:

Application Number: JP,2024-228835

Category (FI): C12N1/19,C07K16/40,C12N15/13,C12N15/63@Z,C12N1/15,C12N1/21,C12N5/10,C12P21/08,C07K16/46,A61P35/00,A61K39/395@N,A61K39/395@T,A61K39/395@U

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Dec. 25, 2024

Publication Date: April 11, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....